BSE filing, NSE: SHAKTIPUMP. Summary written from the filing by ALFA Finder's alert engine.
Shakti Pumps (India) Ltd: key numbers
- Share price
- ₹364.00
- Market cap
- ₹4,492 Cr
- Revenue (annual)
- ₹2,698 Cr
- Net profit (annual)
- ₹257.6 Cr
- P/E (TTM)
- 28.1×Sector 52.0×
- Promoter holding
- 50.40%+0.04% QoQ
- FII holding
- 5.28%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Shakti Pumps (India) Ltd
All →Shakti Pumps (India) Promoter Buying: ₹0.52 Cr
Shakti Pumps promoter group entity Vintex Tools bought 14,000 shares via market purchase, valued at ₹0.52 Crore. Promoter holding rose from 3.98% to 3.99%.
- Value
- ₹0.52 Cr
- Promoter stake change
- +0.01%
Shakti Pumps (India) Promoter Buying: ₹0.48 Cr
Promoter Vintex Tools bought 13,000 Shakti Pumps shares in an open-market purchase on 26 October 2026. Its holding rose from 3.97% to 3.98%.
- Value
- ₹0.48 Cr
- Promoter stake change
- +0.01%
Shakti Pumps (India) Promoter Buying
Vintex Tools, a promoter, bought 13,000 Shakti Pumps shares on the open market. Promoter stake rose marginally from 3.97% to 3.98%.
- Promoter stake change
- +0.01%
Shakti Pumps (India) Earnings Call Transcript: Key Takeaways
Strong volume growth in solar installations and export markets despite regulatory delays in the PM KUSUM scheme.
Shakti Pumps (India) Investor Presentation: Key Takeaways
H1 FY27 revenue ₹16,047 Mn (+24.5% YoY) but PAT fell to ₹901 Mn (5.6% margin) from ₹1,875 Mn. EBITDA margin 9.2% amid geopolitical cost pressure.
Shakti Pumps (India) Results Update
Shakti Pumps reported H1 FY27 revenue up 24.5% to ₹16,047 Mn and PAT of ₹901 Mn. It started trial production at 0.5 GW of solar module capacity.
- solar module capacity
- 0.5 GW
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.